KLOW 80mg

What is KLOW?

KLOW is a multi-peptide research formulation combining GHK-Cu, BPC-157, TB-500 and KPV into a single 80mg blend.

Each component has been investigated independently across different areas of laboratory and preclinical research, including tissue biology, cellular signalling, inflammatory pathways, extracellular-matrix activity and recovery-related mechanisms.

The combination makes KLOW particularly interesting for researchers investigating how multiple peptide pathways may interact within areas of tissue and cellular research.

KLOW is supplied as a lyophilised research compound and is intended strictly for laboratory and scientific research purposes.

What is in KLOW 80mg?

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg

Total peptide content: 80mg per vial

The individual components represent different areas of peptide research, making KLOW a particularly interesting formulation for researchers exploring overlapping biological pathways.

GHK-Cu & Tissue Research

GHK-Cu is a naturally occurring copper-binding peptide that has been extensively investigated in connection with extracellular-matrix biology, collagen-related processes, cellular signalling and tissue research.

Research involving GHK-Cu has explored its relationship with fibroblast activity, extracellular-matrix components and cellular processes involved in tissue maintenance. Because of its association with connective-tissue and matrix biology, GHK-Cu represents an important component of the KLOW formulation for research focused on tissue-related cellular pathways.

BPC-157 Research

BPC-157 is an experimental peptide that has been investigated extensively in preclinical tissue, gastrointestinal, vascular and recovery-related research.

Laboratory and animal studies have explored BPC-157 in relation to cellular signalling, tissue response, vascular mechanisms and gastrointestinal biology. Researchers continue to investigate the biological mechanisms associated with BPC-157, although much of the available evidence remains preclinical.

TB-500 & Cellular Research

TB-500 is commonly associated with research surrounding thymosin-beta-4-related biological pathways. Research in this area has investigated mechanisms involving cell migration, tissue remodelling, angiogenesis and wound-healing biology.

Within KLOW, TB-500 adds another research component focused on cellular repair and tissue-response mechanisms.

KPV & Inflammatory Research

KPV is a short peptide fragment derived from the alpha-melanocyte-stimulating hormone pathway and has been investigated in relation to inflammatory signalling and gastrointestinal research.

Laboratory research has explored KPV's interaction with inflammatory pathways and its potential influence on cellular responses associated with inflammation.

Why is KLOW interesting?

• GHK-Cu: Extracellular-matrix and tissue biology research
• BPC-157: Tissue, gastrointestinal and cellular research
• TB-500: Cell migration and tissue-remodelling research
• KPV: Inflammatory and gastrointestinal research

Together, these components provide researchers with a formulation covering several interconnected areas of cellular signalling, tissue biology and inflammatory research.

Important: Research conducted on an individual component should not automatically be interpreted as evidence for the complete KLOW formulation. Research specifically examining the combined KLOW formulation remains limited.

KLOW & Tissue Research

Several individual components have been studied in laboratory models involving cellular repair, extracellular-matrix activity, cell migration and tissue remodelling. GHK-Cu research has focused heavily on extracellular-matrix biology, while BPC-157 and thymosin-beta-4-related research has investigated cellular and tissue-response mechanisms.

KLOW & Cellular Signalling

The individual peptides contained within KLOW have been investigated across signalling mechanisms involving:

• Cellular communication
• Tissue-response pathways
• Inflammatory signalling
• Extracellular-matrix activity
• Cell migration
• Cellular stress responses

KLOW & Recovery Research

BPC-157 and thymosin-beta-4-related research has explored mechanisms associated with tissue response, cellular migration and repair processes, while GHK-Cu has been investigated in relation to extracellular-matrix and connective-tissue biology. KPV provides an additional research pathway relating to inflammatory signalling.

KLOW & Inflammatory Pathways

KPV has been investigated specifically in relation to inflammatory signalling, while other KLOW components have also been studied in biological processes that interact with tissue response and cellular stress.

What makes KLOW different?

• Four-peptide formulation: GHK-Cu, BPC-157, TB-500 and KPV in one research blend.
• Tissue research: Investigation into pathways associated with tissue biology and cellular repair.
• Extracellular-matrix research: GHK-Cu provides a strong focus on matrix and connective-tissue biology.
• Cellular signalling: Multiple components have been investigated across cellular signalling pathways.
• Inflammatory research: KPV provides an additional focus on inflammatory signalling.
• Recovery research: Individual components have been studied in relation to tissue response and cellular recovery mechanisms.
• Multi-pathway research: Supports investigation of several biological pathways within a single formulation.

A Multi-Peptide Approach to Research

KLOW combines four independently studied compounds into one fixed formulation, encompassing tissue biology, extracellular-matrix activity, cellular signalling, inflammatory pathways and recovery-related mechanisms.

Research specifically evaluating the complete KLOW combination is limited. Further laboratory and scientific investigation is required to understand interactions between the individual components and the formulation as a whole.

Research Areas at a Glance

Tissue Biology • Cellular Signalling • Extracellular-Matrix Research • Cell Migration • Inflammatory Pathways • Gastrointestinal Research • Recovery & Regeneration Research

KLOW 80mg Product Details

• Total peptide content: 80mg
• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg
• BAC Water: Included
• Format: Lyophilised research compound
• Intended use: Laboratory and scientific research only

Research Disclaimer

KLOW is an investigational research compound and is not currently approved by SAHPRA, the FDA, or other major regulatory authorities for therapeutic or consumer applications.

Peptigen products are provided exclusively for laboratory research. Information on this website is presented for general scientific and educational purposes and should not be considered medical advice, a treatment recommendation, or guidance for personal use.

Research involving individual KLOW components does not establish the safety, efficacy or effects of the complete KLOW formulation. Research findings should be interpreted within the context of the specific compound, model and study in which they were obtained.

Peptigen does not provide dosing, administration or reconstitution guidance for research compounds. Purchasers are responsible for ensuring that research materials are handled within an appropriate research environment and in accordance with relevant laws, regulations, laboratory protocols and safety requirements.

Research use only.